Comparative Pharmacology
Head-to-head clinical analysis: REVEFENACIN versus SPIRIVA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: REVEFENACIN versus SPIRIVA.
REVEFENACIN vs SPIRIVA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Revefenacin is a long-acting muscarinic antagonist (LAMA) that inhibits acetylcholine-mediated bronchoconstriction by blocking M3 muscarinic receptors in airway smooth muscle, leading to bronchodilation.
Tiotropium is a long-acting muscarinic antagonist (LAMA) that blocks M3 receptors in the airways, inhibiting acetylcholine-induced bronchoconstriction and mucus secretion.
REVEFENACIN is not a recognized pharmaceutical agent. No standard dosing information available.
18 mcg inhalation via HandiHaler once daily, or 2.5 mcg (2 puffs) via Respimat inhaler once daily.
None Documented
None Documented
Terminal elimination half-life is 12–15 hours in patients with normal renal function (CrCl >90 mL/min). In moderate renal impairment (CrCl 30–59 mL/min), half-life extends to 24 hours. This supports twice-daily dosing in normal patients but may require dose adjustment in renal disease.
Terminal elimination half-life is 27–46 hours (mean ~30 hours) after inhalation. The long half-life supports once-daily dosing due to sustained bronchodilation.
Renal excretion accounts for approximately 70% of elimination, primarily as unchanged drug via glomerular filtration and tubular secretion. Fecal excretion accounts for ~20% with biliary elimination contributing to enterohepatic recirculation. The remaining ~10% is metabolized via CYP3A4 to inactive metabolites.
Renal excretion accounts for approximately 60% (mainly as unchanged drug) following intravenous administration; biliary/fecal excretion accounts for about 30% (as non-absorbed drug after oral inhalation). Less than 20% is metabolized via ester hydrolysis (nonspecific esterases) to inactive metabolites.
Category C
Category C
Anticholinergic Bronchodilator
Anticholinergic Bronchodilator